9/11 Prostate Cancer
Prostate cancer is one of the most common cancers among 9/11 responders and survivors. Turley Hansen & Rosasco represents many men with prostate cancer in cases before the 9/11 Victim Compensation Fund. Our office recently won a $1.4 million award for a NYC Bus Operator with prostate cancer, malignant thymus cancer and chronic asthma. Our office recently won a $980,000 award for an NYPD Inspector with malignant prostate cancer, diabetes mellitus, esophageal reflux (GERD) and obstructive sleep apnea.
Prostate cancer is the most common cancer among men (after skin cancer), but it can often be treated successfully. Research indicates that 9/11 responders have a 15% greater incidence of prostate cancer than the regular population. More than 2 million men in the US are prostate cancer survivors.
The good news is that there are many effective treatments for prostate cancer, including surgical techniques (including da Vinci robotic assisted surgery), proton beam radiation, high-intensity focused ultrasound (HIFU), hormone therapy, chemotherapy, immunotherapy (used to boost the body’s immune system to help fight off or destroy cancer cells) and drugs called angiogenesis inhibitors.
Most recently, the first line Type 2 diabetes drug Metformin has been shown to increase survival rates among men with prostate cancer, among other cancers. While it does not seem to stop the initial diagnosis of prostate cancer, it may be an additional treatment to consider after diagnosis. Read about stories of hope from prostate cancer survivors here.
Prostate cancer often grows very slowly, so 9/11 responders or survivors (especially men who are older or have other serious medical conditions) may never need any medical treatment. Instead, their doctors may recommend conservative approaches known as watchful waiting or active surveillance. Learn more about Prostate Cancer from the American Cancer Society here.
Should you have questions about medical care or an award for prostate cancer from the 9/11 Victim Compensation Fund, please call us at 1-855-982-4636.